Oramed Pharmaceuticals
Insider trading & Transactions

Last updated: 4 Apr 2023

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	4 Apr 2023	MAYER ARIE director director	Common Stock	3,800	$2.21	$8,398
Purchase	3 Apr 2023	MAYER ARIE director director	Common Stock	5,009	$2.22	$11,120
Purchase	16 Mar 2023	KIDRON NADAV director, officer: President and CEO director, officer: President an..	Common Stock	26,000	$2.04	$53,014
Purchase	14 Mar 2023	KIDRON NADAV director, officer: President and CEO director, officer: President an..	Common Stock	100,000	$2.01	$201,000
Sale	14 Mar 2023	KIDRON MIRIAM director, officer: Chief Scientific Officer director, officer: Chief Scient..	Common Stock	100,000	$2.01	$201,000
Purchase	14 Mar 2023	ROZOV YADIN director director	Common Stock	50,000	$2.05	$102,450
Purchase	13 Mar 2023	ROZOV YADIN director director	Common Stock	20,000	$1.96	$39,120
Sale	3 Jan 2023	RABINOWITZ MICHAEL officer: Chief Commercial Officer officer: Chief Commercial Officer	Common Stock	11,900	$12.49	$148,655
Sale	3 Jan 2023	RABINOWITZ MICHAEL officer: Chief Commercial Officer officer: Chief Commercial Officer	Common Stock	1,425	$13.01	$18,544
Option	8 Aug 2022	SANK LEONARD director director	Stock Option	20,000	$4.08	$81,600
Option	8 Aug 2022	SANK LEONARD director director	Common Stock	20,000	$4.08	$81,600
Sale	21 Mar 2022	RAKIN KEVIN director director	Common Stock	10,000	$9.41	$94,100
Option	17 Feb 2022	RAKIN KEVIN director director	Stock Option (right to buy)	6,667	$4.8	$32,002
Option	17 Feb 2022	RAKIN KEVIN director director	Common Stock	6,667	$4.8	$32,002
Sale	16 Sep 2021	RAKIN KEVIN director director	Common Stock	21,100	$20.99	$442,826
Sale	9 Aug 2021	KIDRON NADAV director, 10 percent owner, officer: Presiden.. director, 10 percent owner, off..	Common Stock	220,000	$20.11	$4,423,100
Option	9 Aug 2021	RAKIN KEVIN director director	Common Stock	79,136	$5.74	$454,478
Option	9 Aug 2021	RAKIN KEVIN director director	Stock Option (right to buy)	5,697	$6.23	$35,492
Purchase	9 Sep 2019	SANK LEONARD director director	Common Stock	25,000	N/A	N/A
Purchase	18 Jul 2019	SANK LEONARD director director	Common Stock	4,497	N/A	N/A
Purchase	17 Jul 2019	SANK LEONARD director director	Common Stock	30,020	N/A	N/A
Purchase	17 Jul 2019	SANK LEONARD director director	Common Stock	30,020	N/A	N/A
Purchase	16 Jul 2019	SANK LEONARD director director	Common Stock	20,000	N/A	N/A
Purchase	11 Jul 2019	SANK LEONARD director director	Common Stock	1,320	N/A	N/A
Purchase	9 Aug 2018	FRIEDMAN AVIAD director director	Common Stock	2,500	N/A	N/A
Purchase	9 Aug 2018	FRIEDMAN AVIAD director director	Common Stock	2,500	$4.9	$12,250
Purchase	11 Jul 2018	KIDRON NADAV director, 10 percent owner, officer: Presiden.. director, 10 percent owner, off..	Common Stock	122	N/A	N/A
Sale	10 Jul 2018	KIDRON NADAV director, 10 percent owner, officer: Presiden.. director, 10 percent owner, off..	Common Stock	61	N/A	N/A
Option	31 Oct 2017	SLAGER DAVID MARK director director	Warrant (right to buy)	16,892	N/A	N/A
Option	31 Oct 2017	SLAGER DAVID MARK director director	Common Stock	16,892	N/A	N/A
Option	23 Oct 2017	SANK LEONARD director director	Common Stock	12,004	N/A	N/A
Option	23 Oct 2017	SANK LEONARD director director	Warrant (right to buy)	5,631	N/A	N/A
Option	17 Aug 2017	SLAGER DAVID MARK director director	Warrant (right to buy)	112,613	N/A	N/A
Option	17 Aug 2017	SLAGER DAVID MARK director director	Common Stock	112,613	N/A	N/A
Option	15 Aug 2017	SANK LEONARD director director	Warrant (right to buy)	11,262	N/A	N/A
Option	15 Aug 2017	SANK LEONARD director director	Common Stock	11,262	N/A	N/A
Purchase	2 Aug 2017	LI XIAOPENG director director	COMMON STOCK	89,636	N/A	N/A
Sale	2 Aug 2017	KIDRON MIRIAM director, officer: Chief Scientific Officer director, officer: Chief Scient..	Common Stock	89,636	N/A	N/A
Purchase	19 Apr 2017	LI XIAOPENG director director	Common Stock	52,814	N/A	N/A
Sale	19 Apr 2017	KIDRON MIRIAM director, officer: Chief Scientific Officer director, officer: Chief Scient..	Common Stock	52,814	N/A	N/A
Purchase	12 May 2016	KIDRON NADAV director, 10 percent owner, officer: Presiden.. director, 10 percent owner, off..	Common Stock	1,000	N/A	N/A
Sale	10 Mar 2016	JACOB HAROLD director director	Common Stock	8,500	N/A	N/A
Sale	30 Dec 2015	KIDRON MIRIAM director, officer: Chief Scientific Officer director, officer: Chief Scient..	Common Stock	24,000	N/A	N/A
Sale	29 Dec 2015	KIDRON MIRIAM director, officer: Chief Scientific Officer director, officer: Chief Scient..	Common Stock	15,000	N/A	N/A
Sale	28 Dec 2015	KIDRON MIRIAM director, officer: Chief Scientific Officer director, officer: Chief Scient..	Common Stock	11,000	N/A	N/A
Sale	9 Dec 2015	BERELOWITZ MICHAEL director director	Common Stock	700	N/A	N/A
Sale	8 Dec 2015	BERELOWITZ MICHAEL director director	Common Stock	761	N/A	N/A
Sale	7 Dec 2015	BERELOWITZ MICHAEL director director	Common Stock	539	N/A	N/A
Purchase	27 Oct 2015	REGALS CAPITAL MANAGEMENT LP 10 percent owner 10 percent owner	Call Option (Right to Buy)	1,359	N/A	N/A
Purchase	23 Oct 2015	REGALS CAPITAL MANAGEMENT LP 10 percent owner 10 percent owner	Call Option (Right to Buy)	1,103	N/A	N/A

Showing 1 to 50 of 94 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Oramed Pharmaceuticals Insider trading & Transactions

Insider trading

Who is insider?

Similar companies insider trading:

Oramed Pharmaceuticals
Insider trading & Transactions